Vagustim develops wearable neuromodulation devices designed to support autonomic regulation and overall well-being through auricular vagus nerve stimulation. The company’s platform combines a wearable device with a companion app to deliver targeted stimulation to ear-based vagal nerve pathways. Its approach focuses on non-invasive, at-home use to influence stress, sleep, digestion, and emotional regulation. Vagustim positions its technology within applied neuroscience and consumer wellness contexts rather than clinical therapy.

The technology delivers gentle electrical pulses to auricular nerve branches, engaging neural circuits that modulate autonomic and central nervous system activity. Session parameters are managed via the app, enabling personalized stimulation schedules and tracking. By stimulating vagal afferents, the system aims to promote relaxation, enhance sleep quality, and support digestive function. The platform emphasizes safety, ease of use, and integration into daily routines.

Vagustim targets individuals seeking non-pharmacological tools for stress management, sleep improvement, and overall autonomic support. The device is intended for consumer wellness and self-regulation rather than regulated medical treatment. Its focus reflects growing interest in wearable neuromodulation for enhancing everyday health and emotional resilience.